Conclusions
Data from this study show that there is no difference in absorption rate
and effect between the two preparations of rasagiline. All subjects
showed good tolerance of both preparations without any serious or
unexpected adverse reactions. According to the relevant provisions of
NMPA guidelines, the two tablets were considered bioequivalent for
single dosing under fasting and postprandial conditions.